Global Gene Therapy Market

1. Summary

The Global Gene Therapy Market was valued at $11.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 18.8% CAGR, to an estimated market size of $27.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global gene therapy market involves the introduction, removal, or alteration of genetic material within a patient's cells to treat or prevent disease, encompassing viral and non-viral delivery systems used for oncology, rare diseases, and neurological disorders, while excluding standard mRNA vaccines.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Gene Therapy Market in the period 2025-30:

• The integration of Artificial Intelligence and machine learning is optimizing genomic data analysis and the discovery of novel therapeutic targets.
• There is a significant shift toward non-viral delivery systems, such as lipid nanoparticles, to improve safety profiles and reduce the immunogenicity associated with viral vectors.
• Regulatory bodies are implementing expedited approval pathways to accelerate the commercialization of therapies for rare and ultra-rare genetic disorders.
• The industry is transitioning from manual production to automated manufacturing platforms to enhance scalability and reduce the high costs of personalized treatments.
• A growing focus on in vivo gene editing allows for therapeutic modifications directly within the patient's body, simplifying treatment logistics compared to ex vivo methods.
• The market is increasingly reliant on CDMO partnerships as small biotech firms seek specialized infrastructure for complex GMP-compliant production.
• High treatment costs and limited reimbursement frameworks remain significant barriers to widespread patient access and market penetration.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: